Volume 99, Issue 3

Search all Annals of Hematology articles

March 2020

33 articles in this issue

MicroRNAs: pivotal regulators in acute myeloid leukemia
Mingyu Li
Xianglun Cui
Hongzai Guan
Review Article 13 January 2020 Pages: 399 - 412
Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica)
Giovanna Russo
Vincenzo Guardabasso
Raffaella Colombatti
Original Article 21 January 2020 Pages: 413 - 420
Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels
Negin Shokrgozar
Niloofar Amirian
Sedigheh Sharifzadeh
Original Article 27 January 2020 Pages: 421 - 429
M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload
Jun-Kai Kao
Shih-Chung Wang
Jeng-Jer Shieh
Original Article 01 February 2020 Pages: 431 - 441
Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective
Xiaoqing Liu
Xingyu Lu
Jianyong Li
Original Article 22 January 2020 Pages: 443 - 449
Platelet counts of adults upon acute hospital admission to internal medicine units are a predictor of mortality
Guillaume Moulis
Christian Fynbo Christiansen
Mette Nørgaard
Original Article 13 January 2020 Pages: 451 - 457
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics
Evangelia Kontopoulou
Sarah Strachan
Basant Kumar Thakur
Original Article 13 January 2020 Pages: 459 - 475
Identification of CD318 (CDCP1) as novel prognostic marker in AML
Jonas S. Heitmann
Ilona Hagelstein
Joseph Kauer
Original Article Open access 21 January 2020 Pages: 477 - 486
t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
Wei Xie
Guiling Tang
Shimin Hu
Original Article 31 January 2020 Pages: 487 - 500
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
Yu-Wen Wang
Cheng-Hong Tsai
Hwei-Fang Tien
Original Article 21 January 2020 Pages: 501 - 511
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system
Omar Alkharabsheh
Mrinal M. Patnaik
Aref Al-Kali
Original Article 23 January 2020 Pages: 513 - 518
Improved survival of AML patients by addition of cladribine to standard induction chemotherapy
Saša Anžej Doma
Matevž Škerget
Matjaž Sever
Original Article 23 January 2020 Pages: 519 - 525
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine
Iván Martín
Blanca Navarro
Mar Tormo
Original Article 28 January 2020 Pages: 527 - 537
Phenotypic characterization of macrophages in the BMB sample of human acute leukemia
Jian-Xin Song
Yan Wen
Ya-Lian Sa
Original Article 18 January 2020 Pages: 539 - 547
High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China
Yan Xie
Xiaopei Wang
Ju Zhu
Original Article 24 January 2020 Pages: 549 - 555
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment
Gi-June Min
Young-Woo Jeon
Seok-Goo Cho
Original Article 28 January 2020 Pages: 557 - 570
In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes
Jessica Opie
Katherine Antel
Nicolas Novitzky
Original Article 18 January 2020 Pages: 571 - 578
Correction to: In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes
Jessica Opie
Katherine Antel
Nicolas Novitzky
Correction 19 February 2020 Pages: 579 - 579
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
Limei Xu
Junru Liu
Juan Li
Original Article 21 January 2020 Pages: 581 - 589
Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation
Souichi Shiratori
Hiroyuki Ohigashi
North Japan Hematology Study Group (NJHSG)
Original Article 01 February 2020 Pages: 591 - 598
Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission
Makoto Hirosawa
Takahiro Yamaguchi
Junichi Tsukada
Original Article Open access 31 January 2020 Pages: 599 - 607
NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Adam Kuba
Ludek Raida
Tomas Papajik
Original Article 30 January 2020 Pages: 609 - 618
Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria
Malek Benakli
Redhouane Ahmed Nacer
Rose-Marie Hamladji
Original Article 23 January 2020 Pages: 619 - 625
The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation
Fernanda Toledo Piza Ferraz
Alexandre Rodrigues Marra
Marcelino de Souza Durão Junior
Original Article 21 January 2020 Pages: 627 - 633
Whole body vibration training during allogeneic hematopoietic cell transplantation—the effects on patients’ physical capacity
Antonia Pahl
Anja Wehrle
Hartmut Bertz
Original Article Open access 23 January 2020 Pages: 635 - 648
Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation
George Z. Rassidakis
Olga Stromberg
Kristina Sonnevi
Letter to the Editor 03 February 2020 Pages: 649 - 651
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
Gabriel Pabst
Karin Lind
Heinz Sill
Letter to the Editor Open access 30 January 2020 Pages: 653 - 655
Adrenal failure secondary to bilateral adrenal haemorrhage in heparin-induced thrombocytopenia
Aditya Tedjaseputra
Matthew Sawyer
Michael Sze Yuan Low
Letter to the Editor 14 January 2020 Pages: 657 - 659
Usefulness of azacitidine therapy in a sickle cell disease patient with myelodysplastic syndrome
Gonzalo De Luna
Luc Darnige
Jean-Benoît Arlet
Letter to the Editor 31 January 2020 Pages: 661 - 662
Adult primary hemophagocytic lymphohistocytosis associated with lymphoma
Zhili Jin
Yini Wang
Zhao Wang
Letter to the Editor 30 January 2020 Pages: 663 - 665
Chronic thromboembolic pulmonary hypertension from synchronous idiopathic upper extremity deep vein thrombosis and pulmonary embolism
Hiu Lam Agnes Yuen
Trevor J. Williams
Sanjeev Chunilal
Letter to the Editor 18 January 2020 Pages: 667 - 669
The Glasgow prognostic score divides high-risk hematopoietic cell transplantation-specific comorbidity index patients into stratified subgroups in allogeneic hematopoietic cell transplantation
Yasuhiko Shibasaki
Tatsuya Suwabe
Masayoshi Masuko
Letter to the Editor 03 February 2020 Pages: 671 - 673
Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus
Pau Montesinos
Juan Bergua
Miguel Ángel Sanz
Correction 30 January 2020 Pages: 675 - 675

Volume 99, Issue 3

MicroRNAs: pivotal regulators in acute myeloid leukemia

Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica)

Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels

M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload

Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective

Platelet counts of adults upon acute hospital admission to internal medicine units are a predictor of mortality

Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics

Identification of CD318 (CDCP1) as novel prognostic marker in AML

t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?

Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax

Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system

Improved survival of AML patients by addition of cladribine to standard induction chemotherapy

Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine

Phenotypic characterization of macrophages in the BMB sample of human acute leukemia

High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes

Correction to: In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes

Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma

Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation

Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission

NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria

The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation

Whole body vibration training during allogeneic hematopoietic cell transplantation—the effects on patients’ physical capacity

Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model

Adrenal failure secondary to bilateral adrenal haemorrhage in heparin-induced thrombocytopenia

Usefulness of azacitidine therapy in a sickle cell disease patient with myelodysplastic syndrome

Adult primary hemophagocytic lymphohistocytosis associated with lymphoma

Chronic thromboembolic pulmonary hypertension from synchronous idiopathic upper extremity deep vein thrombosis and pulmonary embolism

The Glasgow prognostic score divides high-risk hematopoietic cell transplantation-specific comorbidity index patients into stratified subgroups in allogeneic hematopoietic cell transplantation

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus

Navigation